Date: 2013-01-10 03:57:04

MorphoSys

TecDAX

Bio-Rad Laboratories

Media Release Martinsried/Munich, Germany, January 10, 2013 MorphoSys Completes Sale of AbD Serotec to Bio-Rad MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that the sale of its research and dia

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 120,84 KB